BDMS Launches Breast Cancer Screening Campaign to Promote Early Detection and Prevention

Bangkok Dusit Medical Services Public Company Limited (BDMS), a premier network of internationally accredited private hospitals, is pleased to announce its Breast Cancer Awareness Month initiative. This campaign aims to encourage early detection and prevention of breast cancer, a leading health risk for women.

BDMS Launches Breast Cancer Screening Campaign to Promote Early Detection and Prevention

In alignment with its commitment to proactive health care, BDMS is offering a special Breast Cancer Screening Package featuring a Digital Mammogram and Ultrasound for just 2,900 Baht. This package will be available for purchase from September 16 to October 31, 2024, with the service redeemable until November 15, 2024. BDMS Launches Breast Cancer Screening Campaign to Promote Early Detection and Prevention

The screening package is available at all six BDMS hospital groups, including Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, The Royal Hospital Group (Cambodia), and BDMS Wellness Clinic.

This comprehensive screening program features both a digital mammogram and ultrasound, which are crucial for identifying early signs of breast cancer and assessing risk. Early detection greatly improves the effectiveness of treatment and prevention when managed under expert care.

BDMS underscores the importance of regular screenings as a vital strategy for early diagnosis, particularly for women aged 40 and over. Regular self-exams and timely medical evaluations are essential, as early detection can significantly reduce the impact of breast cancer.

For more information or to purchase the BDMS Breast Cancer Screening Package, please visit BDMS-affiliated hospitals nationwide or contact us through Health Plaza, Shopee, Lazada, or the LINE OA of participating hospitals.


ข่าวbreast cancer+o:memberวันนี้

AXA Strengthens Cancer Awareness and Prevention Efforts in Thailand

Cancer remains one of the most pressing health challenges in Thailand, with over 180,000 new cases diagnosed in 2022 alone. By 2045, this number is expected to double, underscoring the critical need for increased awareness, early detection, and proactive health measures.* Among the most prevalent cancers in Thailand are liver, lung, and breast cancer**, affecting thousands of individuals and families each year. While medical advancements have improved treatment outcomes, prevention and early

Bangkok Dusit Medical Services Public Com... BDMS Launches Breast Cancer Screening Campaign to Promote Early Detection and Prevention — Bangkok Dusit Medical Services Public Company Limited (BDMS), a...

Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio

On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection , securing exclusive commercialization licensing and supply of...

Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications

KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates with poor...

Mr. Poonsit Wongthawatchai (left), Krungs... Krungsri supports Breast Foundation in screening breast cancer for disadvantaged women for 14th year — Mr. Poonsit Wongthawatchai (left), Krungsri Executi...